[Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"].
Störh
M
M
D003245:Consensus Statements as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011239:Prednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D020551:Pulse Therapy, Drug
D007166:Immunosuppressive Agents; D011239:Prednisolone; C021322:prednisolone hemisuccinate; D008775:Methylprednisolone